Koala Health, a pet health company focused on transforming the healthcare experience, announced the closing of a $20 million Series B funding round led by Valspring Capital.
What the funding will be used for: With this funding, Koala will advance its mission to modernize pet care through further developing its mobile-first digital experience and enhancing service offerings for both pet parents and veterinarians.
Value proposition: Koala Health provides a streamlined way for pet owners to access their pets’ medications, available in all 50 states through its online storefront at Koala.health. Now, more than 80 million pet parents can benefit from the platform. And for veterinarians, Koala offers a fully integrated prescription solution available to over 25,000 independent vet clinics nationwide—eliminating the burden of in-house medication storage and fulfillment.
By bridging the gap between veterinarians and pet parents, Koala Health is setting a new standard in pet medication delivery—enhancing the overall quality of care for pets everywhere.
KEY QUOTES:
“Koala Health is redefining the pet prescription experience by building a seamless bridge between veterinarians and pet parents. By partnering directly with clinics and making it easier for pet owners to manage medications, Koala is creating a smarter, more efficient ecosystem that benefits everyone involved. It’s a modern solution to a long-overdue problem in veterinary care.”
Yumin Choi of Valspring Capital
“Veterinary clinics are busier than ever, and many pet owners are facing long wait times for appointments. At Koala, we make it easy to stay on top of pet medications by working directly with both pet parents and their veterinarians—saving time and providing greater peace of mind when it comes to a pet’s health.”
Gavin Cotter, CEO and founder of Koala
